Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Suyuan Evidence Based Technology is a specialized healthcare technology and service provider based in China, focusing on Real-World Evidence (RWE) and Evidence-Based Medicine (EBM). The company offers a comprehensive suite of digital solutions, including Electronic Data Capture (EDC) systems, Clinical Trial Management Systems (CTMS), and advanced data analytics platforms designed for post-marketing surveillance and real-world studies. By integrating clinical research with big data technology, Suyuan supports pharmaceutical companies and medical institutions in generating high-quality clinical evidence to optimize drug development and clinical practice. Their services span across various therapeutic areas, providing end-to-end support from study design to data publication.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Suyuan Evidence Based Technology.